Overview

Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Study to find the optimal dose of Growth Hormone Replacement in young adult patients suffering from childhood onset growth hormone deficiency (GHD).
Phase:
Phase 2
Details
Lead Sponsor:
Ambrx, Inc.
Collaborator:
Merck Serono International SA
Treatments:
Hormones